BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 14607875)

  • 1. Evolution of two amino acid positions governing broad neutralization resistance in a strain of feline immunodeficiency virus over 7 years of persistence in cats.
    Pistello M; Matteucci D; Giannecchini S; Bonci F; Sichi O; Presciuttini S; Bendinelli M
    Clin Diagn Lab Immunol; 2003 Nov; 10(6):1109-16. PubMed ID: 14607875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. During readaptation in vivo, a tissue culture-adapted strain of feline immunodeficiency virus reverts to broad neutralization resistance at different times in individual hosts but through changes at the same position of the surface glycoprotein.
    Bendinelli M; Pistello M; Del Mauro D; Cammarota G; Maggi F; Leonildi A; Giannecchini S; Bergamini C; Matteucci D
    J Virol; 2001 May; 75(10):4584-93. PubMed ID: 11312328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feline immunodeficiency virus-infected cat sera associated with the development of broad neutralization resistance in vivo drive similar reversions in vitro.
    Giannecchini S; Matteucci D; Ferrari A; Pistello M; Bendinelli M
    J Virol; 2001 Sep; 75(18):8868-73. PubMed ID: 11507234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus neutralization reveals antigenic variation among feline immunodeficiency virus isolates.
    Osborne R; Rigby M; Siebelink K; Neil JC; Jarrett O
    J Gen Virol; 1994 Dec; 75 ( Pt 12)():3641-5. PubMed ID: 7996159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the SU can modulate the susceptibility of feline immunodeficiency virus to TM-derived entry inhibitors.
    Giannecchini S; Pistello M; Del Santo B; Rovero P; Sichi O; Bendinelli M
    New Microbiol; 2004 Apr; 27(2 Suppl 1):77-84. PubMed ID: 15646068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of enzymatic deglycosylation on feline immunodeficiency virus sensitivity to antibody-mediated neutralization.
    Giannecchini S; Matteucci D; Bendinelli M
    AIDS Res Hum Retroviruses; 1998 Feb; 14(3):199-204. PubMed ID: 9491909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination of cats with recombinant envelope glycoprotein of feline immunodeficiency virus: decreased viral load after challenge infection.
    Lutz H; Hofmann-Lehmann R; Leutenegger C; Allenspach K; Cuisinier AM; Cronier J; Duquesne V; Aubert A
    AIDS Res Hum Retroviruses; 1996 Mar; 12(5):431-3. PubMed ID: 8882327
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental mucosal infection with molecularly cloned feline immunodeficiency viruses.
    Kohmoto M; Ikeda Y; Sato E; Nishimura Y; Inoshima Y; Shimojima M; Tohya Y; Mikami T; Miyazawa T
    Clin Diagn Lab Immunol; 2003 Jan; 10(1):185-8. PubMed ID: 12522061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in feline immunodeficiency (FIV) virus envelope gene V3-V5 regions in FIV-infected cats.
    Motokawa K; Hohdatsu T; Imori A; Arai S; Koyama H
    Vet Microbiol; 2005 Mar; 106(1-2):33-40. PubMed ID: 15737471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feline Immunodeficiency Virus Evolutionarily Acquires Two Proteins, Vif and Protease, Capable of Antagonizing Feline APOBEC3.
    Yoshikawa R; Takeuchi JS; Yamada E; Nakano Y; Misawa N; Kimura Y; Ren F; Miyazawa T; Koyanagi Y; Sato K
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralization sensitivity and accessibility of continuous B cell epitopes of the feline immunodeficiency virus envelope.
    Richardson J; Fossati I; Moraillon A; Castelot S; Sonigo P; Pancino G
    J Gen Virol; 1996 Apr; 77 ( Pt 4)():759-71. PubMed ID: 8627265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proviral load determination of different feline immunodeficiency virus isolates using real-time polymerase chain reaction: influence of mismatches on quantification.
    Klein D; Janda P; Steinborn R; Müller M; Salmons B; Günzburg WH
    Electrophoresis; 1999 Feb; 20(2):291-9. PubMed ID: 10197436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrahost evolution of envelope glycoprotein and OrfA sequences after experimental infection of cats with a molecular clone and a biological isolate of feline immunodeficiency virus.
    Huisman W; Schrauwen EJ; Rimmelzwaan GF; Osterhaus AD
    Virus Res; 2008 Oct; 137(1):24-32. PubMed ID: 18602181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G glycoprotein amino acid residues required for human monoclonal antibody RAB1 neutralization are conserved in rabies virus street isolates.
    Wang Y; Rowley KJ; Booth BJ; Sloan SE; Ambrosino DM; Babcock GJ
    Antiviral Res; 2011 Aug; 91(2):187-94. PubMed ID: 21693135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phylogenetic analysis of feline immunodeficiency virus isolated from cats in Taiwan.
    Inada G; Miyazawa T; Inoshima Y; Kohmoto M; Ikeda Y; Liu CH; Lin JA; Kuo TF; Mikami T
    Arch Virol; 1997; 142(7):1459-67. PubMed ID: 9267455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmission of feline immunodeficiency virus (FIV) among cohabiting cats in two cat rescue shelters.
    Litster AL
    Vet J; 2014 Aug; 201(2):184-8. PubMed ID: 24698667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Naturally Occurring Domestic Cat APOBEC3 Variant Confers Resistance to Feline Immunodeficiency Virus Infection.
    Yoshikawa R; Izumi T; Yamada E; Nakano Y; Misawa N; Ren F; Carpenter MA; Ikeda T; Münk C; Harris RS; Miyazawa T; Koyanagi Y; Sato K
    J Virol; 2016 Jan; 90(1):474-85. PubMed ID: 26491161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA.
    Lockridge KM; Chien M; Dean GA; Stefano Cole K; Montelaro RC; Luciw PA; Sparger EE
    Virology; 2000 Jul; 273(1):67-79. PubMed ID: 10891409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of feline immunodeficiency virus multiple infection and genome divergence in a free-ranging population of African lions.
    Troyer JL; Pecon-Slattery J; Roelke ME; Black L; Packer C; O'Brien SJ
    J Virol; 2004 Apr; 78(7):3777-91. PubMed ID: 15016897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced sensitivity to strain-specific neutralization of laboratory-adapted feline immunodeficiency virus after one passage in vivo: association with amino acid substitutions in the V4 region of the surface glycoprotein.
    Cammarota G; Matteucci D; Pistello M; Nicoletti E; Giannecchini S; Bendinelli M
    AIDS Res Hum Retroviruses; 1996 Jan; 12(2):173-175. PubMed ID: 8834468
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.